66 research outputs found
Scandiatransplant acceptable mismatch program-10 years with an effective strategy for transplanting highly sensitized patients
In March 2009, the Scandiatransplant acceptable mismatch program (STAMP) was introduced as a strategy toward improving kidney allocation to highly sensitized patients. Patients with a transplantability scorePeer reviewe
Acute antibody-mediated rejection after ABO-incompatible kidney transplantation treated successfully of Transplantation 11 with antigen-specific immunoadsorption,” Nephrology Dialysis Transplantation
Abstract ABO-incompatible kidney transplantation is possible after pre-treatment with rituximab, intravenous immunoglobulin and basiliximab combined with tacrolimus, mycophenolate mofetil and prednisolone. We report on the first patient treated with this protocol who developed acute antibody-mediated rejection (Banff grade II with IgG deposits) caused by ABO antibodies (anti-B). Antirejection treatment with anti-B-specific immunoadsorption, intravenous immunoglobulin and methylprednisolone efficiently cleared deposited IgG from the kidney allograft and re-established normal kidney function. We suggest that ABO-incompatible kidney transplantation complicated by acute antibody-mediated rejection, caused by ABO antibodies, may successfully be treated with this regime
- …